 Paul Menard-Katcher
Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophilic Esophagitis | 12 | 2023 | 296 | 1.730 |
Why?
| | Esophagus | 6 | 2021 | 225 | 1.090 |
Why?
| | Hernia, Hiatal | 3 | 2022 | 31 | 0.900 |
Why?
| | Esophageal Motility Disorders | 3 | 2020 | 23 | 0.860 |
Why?
| | Gastroenterology | 5 | 2021 | 159 | 0.600 |
Why?
| | Esophagogastric Junction | 2 | 2023 | 42 | 0.570 |
Why?
| | Myotomy | 2 | 2023 | 8 | 0.440 |
Why?
| | Eosinophilia | 3 | 2022 | 186 | 0.430 |
Why?
| | Esophagitis, Peptic | 2 | 2023 | 16 | 0.410 |
Why?
| | Laryngopharyngeal Reflux | 2 | 2021 | 13 | 0.380 |
Why?
| | Manometry | 3 | 2020 | 89 | 0.340 |
Why?
| | Gastritis | 2 | 2022 | 84 | 0.320 |
Why?
| | Enteritis | 2 | 2022 | 82 | 0.320 |
Why?
| | Eosinophils | 3 | 2020 | 278 | 0.310 |
Why?
| | Endoscopy, Digestive System | 3 | 2020 | 110 | 0.310 |
Why?
| | Patient Reported Outcome Measures | 2 | 2021 | 250 | 0.290 |
Why?
| | Clinical Competence | 5 | 2022 | 893 | 0.270 |
Why?
| | Deglutition Disorders | 2 | 2022 | 118 | 0.270 |
Why?
| | Quality of Life | 4 | 2023 | 2353 | 0.260 |
Why?
| | Zenker Diverticulum | 1 | 2023 | 4 | 0.220 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2023 | 26 | 0.220 |
Why?
| | Esophageal Achalasia | 1 | 2023 | 25 | 0.210 |
Why?
| | Learning Curve | 2 | 2020 | 63 | 0.200 |
Why?
| | Hyperplasia | 2 | 2020 | 163 | 0.200 |
Why?
| | Balloon Occlusion | 1 | 2022 | 26 | 0.200 |
Why?
| | Tetraspanins | 1 | 2021 | 15 | 0.190 |
Why?
| | Simulation Training | 1 | 2022 | 61 | 0.190 |
Why?
| | Esophageal Stenosis | 1 | 2021 | 45 | 0.190 |
Why?
| | Interleukin-13 | 1 | 2021 | 122 | 0.180 |
Why?
| | Colonoscopy | 2 | 2020 | 204 | 0.180 |
Why?
| | Fellowships and Scholarships | 3 | 2021 | 227 | 0.170 |
Why?
| | Adult | 15 | 2023 | 30553 | 0.170 |
Why?
| | Cytokines | 2 | 2020 | 1841 | 0.160 |
Why?
| | Competency-Based Education | 2 | 2020 | 65 | 0.160 |
Why?
| | Male | 18 | 2023 | 55606 | 0.160 |
Why?
| | Prospective Studies | 7 | 2023 | 6220 | 0.150 |
Why?
| | Humans | 27 | 2023 | 114698 | 0.150 |
Why?
| | Barrett Esophagus | 1 | 2020 | 147 | 0.140 |
Why?
| | Female | 17 | 2023 | 59520 | 0.140 |
Why?
| | Proton Pump Inhibitors | 2 | 2021 | 96 | 0.140 |
Why?
| | Colon | 1 | 2019 | 233 | 0.140 |
Why?
| | Fibroblasts | 1 | 2021 | 838 | 0.140 |
Why?
| | Colitis | 1 | 2019 | 223 | 0.130 |
Why?
| | Endothelial Cells | 1 | 2021 | 687 | 0.130 |
Why?
| | Child | 10 | 2022 | 18420 | 0.130 |
Why?
| | Transition to Adult Care | 1 | 2017 | 62 | 0.130 |
Why?
| | Middle Aged | 10 | 2023 | 26738 | 0.130 |
Why?
| | Education, Medical, Graduate | 2 | 2022 | 368 | 0.130 |
Why?
| | Microbiota | 1 | 2022 | 647 | 0.120 |
Why?
| | Self Report | 1 | 2018 | 696 | 0.120 |
Why?
| | Curriculum | 2 | 2022 | 819 | 0.110 |
Why?
| | Parents | 2 | 2018 | 1186 | 0.110 |
Why?
| | Basophils | 1 | 2013 | 64 | 0.110 |
Why?
| | Aged | 6 | 2023 | 19074 | 0.100 |
Why?
| | Internship and Residency | 1 | 2021 | 926 | 0.100 |
Why?
| | Child, Preschool | 4 | 2021 | 9118 | 0.090 |
Why?
| | Adolescent | 6 | 2021 | 17853 | 0.090 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 4410 | 0.090 |
Why?
| | Endoscopy, Gastrointestinal | 2 | 2022 | 203 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2018 | 2540 | 0.080 |
Why?
| | Esophagoscopy | 2 | 2023 | 184 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1183 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2016 | 3003 | 0.080 |
Why?
| | Young Adult | 4 | 2021 | 10471 | 0.080 |
Why?
| | Glucocorticoids | 1 | 2012 | 532 | 0.080 |
Why?
| | Accreditation | 2 | 2020 | 76 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 57 | 0.070 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 4624 | 0.060 |
Why?
| | Age Factors | 1 | 2012 | 2894 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2320 | 0.060 |
Why?
| | Colitis, Ulcerative | 1 | 2006 | 105 | 0.060 |
Why?
| | Treatment Outcome | 3 | 2023 | 9088 | 0.060 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2023 | 10 | 0.060 |
Why?
| | Program Evaluation | 2 | 2020 | 822 | 0.050 |
Why?
| | Fluticasone | 1 | 2023 | 87 | 0.050 |
Why?
| | Time Factors | 1 | 2012 | 6116 | 0.050 |
Why?
| | Fundoplication | 1 | 2022 | 53 | 0.050 |
Why?
| | Herniorrhaphy | 1 | 2022 | 48 | 0.050 |
Why?
| | Phenotype | 2 | 2021 | 2796 | 0.050 |
Why?
| | Printing, Three-Dimensional | 1 | 2022 | 61 | 0.050 |
Why?
| | Stomach | 1 | 2022 | 102 | 0.050 |
Why?
| | Esophageal Sphincter, Upper | 1 | 2021 | 5 | 0.050 |
Why?
| | Proton Pumps | 1 | 2021 | 8 | 0.050 |
Why?
| | Heartburn | 1 | 2021 | 11 | 0.050 |
Why?
| | Pepsin A | 1 | 2021 | 18 | 0.050 |
Why?
| | Gene Silencing | 1 | 2021 | 171 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2006 | 1141 | 0.050 |
Why?
| | Dilatation | 1 | 2021 | 60 | 0.050 |
Why?
| | International Cooperation | 1 | 2021 | 171 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 186 | 0.040 |
Why?
| | Cough | 1 | 2021 | 107 | 0.040 |
Why?
| | United Arab Emirates | 1 | 2020 | 5 | 0.040 |
Why?
| | Cohort Studies | 2 | 2020 | 4895 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2021 | 535 | 0.040 |
Why?
| | United States | 3 | 2023 | 12186 | 0.040 |
Why?
| | Feedback | 1 | 2019 | 144 | 0.040 |
Why?
| | Precancerous Conditions | 1 | 2020 | 158 | 0.040 |
Why?
| | International Classification of Diseases | 1 | 2019 | 116 | 0.040 |
Why?
| | Diagnostic Errors | 1 | 2019 | 149 | 0.040 |
Why?
| | Leukocyte Count | 1 | 2018 | 293 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2020 | 740 | 0.030 |
Why?
| | Patient Discharge | 1 | 2022 | 773 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2017 | 539 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1421 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1342 | 0.030 |
Why?
| | Machine Learning | 1 | 2018 | 316 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2023 | 4411 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1036 | 0.030 |
Why?
| | Self Care | 1 | 2017 | 349 | 0.030 |
Why?
| | Benchmarking | 1 | 2015 | 161 | 0.030 |
Why?
| | Neutralization Tests | 1 | 2013 | 63 | 0.030 |
Why?
| | Disease Progression | 1 | 2020 | 2380 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2020 | 12555 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1320 | 0.030 |
Why?
| | Data Collection | 1 | 2015 | 620 | 0.020 |
Why?
| | Immunoglobulin E | 1 | 2013 | 314 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1518 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 2968 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1144 | 0.020 |
Why?
| | Animals | 2 | 2023 | 31708 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2013 | 1262 | 0.020 |
Why?
| | Risk Factors | 1 | 2020 | 8632 | 0.020 |
Why?
| | Ki-67 Antigen | 1 | 2006 | 103 | 0.020 |
Why?
| | Epithelium | 1 | 2006 | 295 | 0.020 |
Why?
| | Regeneration | 1 | 2006 | 160 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2006 | 396 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 4694 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2013 | 3535 | 0.010 |
Why?
| | DNA Damage | 1 | 2006 | 351 | 0.010 |
Why?
| | Kinetics | 1 | 2006 | 1551 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 2006 | 532 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2006 | 951 | 0.010 |
Why?
| | Mice | 1 | 2013 | 14871 | 0.010 |
Why?
| | Inflammation | 1 | 2006 | 2480 | 0.010 |
Why?
|
|
Menard-Katcher's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|